> Boston Scientific has upped the ante to buy Guidant, offering $25 billion. Report
> The UK's Antisoma has raised $11 million through the sale of shares. Release
> PDI is discontinuing its InServe business unit. Release
> Canada's Generex Biotechnology has raised $3.5 million. Release
> Novelos Therapeutics got a green light from the FDA to advance its therapy for advanced non-small cell lung cancer into Phase III. Release
And Finally… Despite being delayed by Hurricane Katrina, Louisiana and Tulane University will push ahead with plans to create the New Orleans BioInnovation Center. Article